SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001053691-17-000014
Filing Date
2017-05-15
Accepted
2017-05-15 16:53:02
Documents
3
Period of Report
2017-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dffn-form8xk2017q1financia.htm 8-K 20104
2 EXHIBIT 99.1 dffnq117earningsrelease.htm EX-99.1 17935
3 dffnq117earningsrelea_image2.jpg GRAPHIC 17381
  Complete submission text file 0001053691-17-000014.txt   63567
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 17845220
SIC: 2834 Pharmaceutical Preparations